Scholarlink

<p>Protein binders that detect, activate, inhibit, or otherwise modulate their targets are pivotal for biomedical applications. With the increasing accuracy and accessibility of de novo protein design, faster and cheaper experimental screening methods would democratize and accelerate the identification of high-affinity binders. Here we present Cell-Free Two-Hybrid (CF2H), a rapid and sensitive method for detecting high-affinity protein-protein interactions (PPI) that does not require cloning, protein purification nor high-end laboratory equipment. CF2H uses a dimerization-activated DNA binding domain (DBD) fused to prey and bait proteins to trigger transcription upon protein-protein interaction. We demonstrate that CF2H enables the detection of interactions between various types of target and binder proteins such as single-domain antibodies, DARPins, and de novo designed binders. We benchmark CF2H as a screening platform by validating previously reported binders for Mdm2 and discovering high-affinity binders targeting the checkpoint inhibitor PD-L1 in less than 24 hours. Finally, we show that CF2H can be used to characterize small-molecule modulators of PPI and detect protein biomarkers, opening the door for a new class of cell-free biosensors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

CF2H: a cell-free two-hybrid platform for rapid protein binder screening

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月10日

查看全文
  • Julien Capin,
  • Pauline Mayonove,
  • Angelique DeVisch,
  • Amon Becher,
  • Giang Ngo,
  • Alexis Courbet,
  • Robert J. Ragotte,
  • Martin Cohen Gonsaud,
  • Julien Espeut,
  • Jerome Bonnet

摘要

Protein binders that detect, activate, inhibit, or otherwise modulate their targets are pivotal for biomedical applications. With the increasing accuracy and accessibility of de novo protein design, faster and cheaper experimental screening methods would democratize and accelerate the identification of high-affinity binders. Here we present Cell-Free Two-Hybrid (CF2H), a rapid and sensitive method for detecting high-affinity protein-protein interactions (PPI) that does not require cloning, protein purification nor high-end laboratory equipment. CF2H uses a dimerization-activated DNA binding domain (DBD) fused to prey and bait proteins to trigger transcription upon protein-protein interaction. We demonstrate that CF2H enables the detection of interactions between various types of target and binder proteins such as single-domain antibodies, DARPins, and de novo designed binders. We benchmark CF2H as a screening platform by validating previously reported binders for Mdm2 and discovering high-affinity binders targeting the checkpoint inhibitor PD-L1 in less than 24 hours. Finally, we show that CF2H can be used to characterize small-molecule modulators of PPI and detect protein biomarkers, opening the door for a new class of cell-free biosensors.